Immunosuppressive effect of quercetin on dendritic cell activation and function

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 6815-6821

  Huang, Ren Yeong ^a   Yu, Yen Ling ^b   Cheng, Wan Chien ^a   OuYang, Chun Nan ^b   Fu, Earl ^a   Chu, Ching Liang ^b,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; QUERCETIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL FUNCTION; CHRONIC INFLAMMATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENDOCYTOSIS; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; QUERCETIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77953631110     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903991     Document Type: Article

References (58)

1. Buckwalter, M. R., and M. L. Albert. 2009. Orchestration of the immune response by dendritic cells. Curr. Biol. 19: R355-R361.
2. Joffre, O., M. A. Nolte, R. Spörri, and C. Reis e Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227: 234-247.
3. Kumar, H., T. Kawai, and S. Akira. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388: 621-625.
4. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
5. Galkina, E., and K. Ley. 2009. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27: 165-197.
6. Oyoshi, M. K., R. He, L. Kumar, J. Yoon, and R. S. Geha. 2009. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102: 135-226.
7. Ganesan, A. 2008. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 12: 306-317.
8. Patil, B. S., G. K. Jayaprakasha, K. N. Chidambara Murthy, and A. Vikram. 2009. Bioactive compounds: historical perspectives, opportunities, and challenges. J. Agric. Food Chem. 57: 8142-8160.
9. García-Lafuente, A., E. Guillamón, A. Villares, M. A. Rostagno, and J. A. Martínez. 2009. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 58: 537-552.
10. Mota, K. S., G. E. Dias, M. E. Pinto, A. Luiz-Ferreira, A. R. Souza-Brito, C. A. Hiruma-Lima, J. M. Barbosa-Filho, and L. M. Batista. 2009. Flavonoids with gastroprotective activity. Molecules 14: 979-1012.
11. Petti, S., and C. Scully. 2009. Polyphenols, oral health and disease: A review. J. Dent. 37: 413-423.
12. Spencer, J. P. 2009. The impact of flavonoids on memory: physiological and molecular considerations. Chem. Soc. Rev. 38: 1152-1161.
13. Yang, C.S.,X.Wang, G.Lu, and S. C. Picinich. 2009. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 9: 429-439.
14. Magrone, T., G. Candore, C. Caruso, E. Jirillo, and V. Covelli. 2008. Polyphenols from red wine modulate immune responsiveness: biological and clinical significance. Curr. Pharm. Des. 14: 2733-2748.
15. Boots, A. W., G. R. Haenen, and A. Bast. 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585: 325-337.
16. Bischoff, S. C. 2008. Quercetin: potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care 11: 733-740.
17. Yu, C. S., K. C. Lai, J. S. Yang, J. H. Chiang, C. C. Lu, C. L. Wu, J. P. Lin, C. L. Liao, N. Y. Tang, W. G. Wood, and J. G. Chung. 2010. Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Phytother. Res. 24: 163-168.
18. Kim, A. R., J. Y. Cho, Y. Zou, J. S. Choi, and H. Y. Chung. 2005. Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells. Arch. Pharm. Res. 28: 297-304.
19. Min, Y. D., C. H. Choi, H. Bark, H. Y. Son, H. H. Park, S. Lee, J. W. Park, E. K. Park, H. I. Shin, and S. H. Kim. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 56: 210-215.
20. Moreira, M. R., A. Kanashiro, L. M. Kabeya, A. C. Polizello, A. E. Azzolini, C. Curti, C. A. Oliveira, A. T-do Amaral, and Y. M. Lucisano-Valim. 2007. Neutrophil effector functions triggered by Fc-γ and/or complement receptors are dependent on B-ring hydroxylation pattern and physicochemical properties of flavonols. Life Sci. 81: 317-326.
21. Gong, J., and S. S. Chen. 2003. Polyphenolic antioxidants inhibit peptide presentation by antigen-presenting cells. Int. Immunopharmacol. 3: 1841-1852.
22. Yu, E. S., H. J. Min, S. Y. An, H. Y. Won, J. H. Hong, and E. S. Hwang. 2008. Regulatory mechanisms of IL-2 and IFNγ suppression by quercetin in T helper cells. Biochem. Pharmacol. 76: 70-78.
23. Kim, J. S., and C. Jobin. 2005. The flavonoid luteolin prevents lipopolysaccharide- induced NF-κB signalling and gene expression by blocking IκB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115: 375-387.
24. Yoon, M. S., J. S. Lee, B. M. Choi, Y. I. Jeong, C. M. Lee, J. H. Park, Y. Moon, S. C. Sung, S. K. Lee, Y. H. Chang, et al. 2006. Apigenin inhibits immunostimulatory function of dendritic cells: implication of immunotherapeutic adjuvant. Mol. Pharmacol. 70: 1033-1044.
25. Lee, J. S., S. G. Kim, H. K. Kim, T. H. Lee, Y. I. Jeong, C. M. Lee, M. S. Yoon, Y. J. Na, D. S. Suh, N. C. Park, et al. 2007. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J. Cell. Physiol. 210: 385-397.
26. Kim, Y. J., S. E. Choi, M. W. Lee, and C. S. Lee. 2008. Taxifolin glycoside inhibits dendritic cell responses stimulated by lipopolysaccharide and lipoteichoic acid. J. Pharm. Pharmacol. 60: 1465-1472.
27. Yoneyama, S., K. Kawai, N. H. Tsuno, Y. Okaji, M. Asakage, T. Tsuchiya, J. Yamada, E. Sunami, T. Osada, J. Kitayama, et al. 2008. Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J. Allergy Clin. Immunol. 121: 209-214.
28. Chu, C. L., and C. A. Lowell. 2005. The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation. J. Immunol. 175: 2880-2889.
29. Chu, C. L., Y. L. Yu, K. Y. Shen, C. A. Lowell, L. L. Lanier, and J. A. Hamerman. 2008. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma. Eur. J. Immunol. 38: 166-173.
30. Yu, Y. L., I. H. Chen, K. Y. Shen, R. Y. Huang, W. R. Wang, C. J. Chou, T. T. Chang, and C. L. Chu. 2009. A triterpenoid methyl antcinate K isolated from Antrodia cinnamomea promotes dendritic cell activation and Th2 differentiation. Eur. J. Immunol. 39: 2482-2491.
31. Liu, Q., T. Chen, G. Chen, X. Shu, A. Sun, P. Ma, L. Lu, and X. Cao. 2007. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways. Mol. Immunol. 44: 2686-2696.
32. Chen, J. P., N. S. Liao, S. L. Lai, L. Hsu, W. Y. Mao, M. C. Ku, and F. Liao. 2005. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor α-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression. Eur. J. Immunol. 35: 690-698.
33. Böhl, M., S. Tietze, A. Sokoll, S. Madathil, F. Pfennig, J. Apostolakis, K. Fahmy, and H. O. Gutzeit. 2007. Flavonoids affect actin functions in cytoplasm and nucleus. Biophys. J. 93: 2767-2780.
34. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371.
35. Nam, N. H. 2006. Naturally occurring NF-κB inhibitors. Mini Rev. Med. Chem. 6: 945-951.
36. Kim, B. H., I. J. Lee, H. Y. Lee, S. B. Han, J. T. Hong, B. Ahn, C. K. Lee, and Y. Kim. 2007. Quercetin 3-O-β-(2″-galloyl)-glucopyranoside inhibits endotoxin LPS-induced IL-6 expression and NF-κB activation in macrophages. Cytokine 39: 207-215.
37. Kaneko, M., H. Takimoto, T. Sugiyama, Y. Seki, K. Kawaguchi, and Y. Kumazawa. 2008. Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors. Immunopharmacol. Immunotoxicol. 30: 867-882.
38. Cho, S. Y., S. J. Park, M. J. Kwon, T. S. Jeong, S. H. Bok, W. Y. Choi, W. I. Jeong, S. Y. Ryu, S. H. Do, C. S. Lee, et al. 2003. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-κB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell. Biochem. 243: 153-160.
39. Comalada, M., D. Camuesco, S. Sierra, I. Ballester, J. Xaus, J. Gálvez, and A. Zarzuelo. 2005. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur. J. Immunol. 35: 584-592.
40. Hämäläinen, M., R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen. 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007: 45673. (Pubitemid 47388729)
41. Lee, J. K., S. Y. Kim, Y. S. Kim, W. H. Lee, D. H. Hwang, and J. Y. Lee. 2009. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem. Pharmacol. 77: 1391-1400.
42. Esser, C., A. Rannug, and B. Stockinger. 2009. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30: 447-454.
43. Kimura, A., T. Naka, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto. 2008. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. USA 105: 9721-9726.
44. Veldhoen, M., K. Hirota, A. M.Westendorf, J. Buer, L. Dumoutier, J. C. Renauld, and B. Stockinger. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109. (Pubitemid 351630329)
45. Quintana, F. J., A. S. Basso, A. H. Iglesias, T. Korn, M. F. Farez, E. Bettelli, M. Caccamo, M. Oukka, and H. L. Weiner. 2008. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
46. Kimura, A., T. Naka, T. Nakahama, I. Chinen, K. Masuda, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto. 2009. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206: 2027-2035.
47. Lawrence, B. P., M. S. Denison, H. Novak, B. A. Vorderstrasse, N. Harrer, W. Neruda, C. Reichel, and M. Woisetschläger. 2008. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 112: 1158-1165.
48. Jux, B., S. Kadow, and C. Esser. 2009. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J. Immunol. 182: 6709-6717.
49. Haarmann-Stemmann, T., H. Bothe, and J. Abel. 2009. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem. Pharmacol. 77: 508-520.
50. Esser, C. 2009. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem. Pharmacol. 77: 597-607.
51. Muthian, G., and J. J. Bright. 2004. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J. Clin. Immunol. 24: 542-552.
52. Mamani-Matsuda, M., T. Kauss, A. Al-Kharrat, J. Rambert, F. Fawaz, D. Thiolat, D. Moynet, S. Coves, D. Malvy, and M. D. Mossalayi. 2006. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem. Pharmacol. 72: 1304-1310.
53. Tang, D., R. Kang, W. Xiao, H. Zhang, M. T. Lotze, H. Wang, and X. Xiao. 2009. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am. J. Respir. Cell Mol. Biol. 41: 651-660.
54. Hauben, E., S. Gregori, E. Draghici, B. Migliavacca, S. Olivieri, M. Woisetschläger, andM. G. Roncarolo. 2008. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112: 1214-1222.
55. Kerkvliet, N. I., L. B. Steppan, W. Vorachek, S. Oda, D. Farrer, C. P. Wong, D. Pham, and D. V. Mourich. 2009. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3 T cells in pancreatic lymph nodes. Immunotherapy 1: 539-547.
56. Harwood, M., B. Danielewska-Nikiel, J. F. Borzelleca, G. W. Flamm, G. M. Williams, and T. C. Lines. 2007. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45: 2179-2205.
57. Ghosh, A., A. K. Mandal, S. Sarkar, S. Panda, and N. Das. 2009. Nano-encapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci. 84: 75-80.
58. Capini, C., M. Jaturanpinyo, H. I. Chang, S. Mutalik, A. McNally, S. Street, R. Steptoe, B. O'Sullivan, N. Davies, and R. Thomas. 2009. Antigen-specific suppression of inflammatory arthritis using liposomes. J. Immunol. 182: 3556-3565.